Global Breast Cancer Diagnosis Market - Forecasts From 2018 to 2023

The global Breast Cancer Diagnosis market is expected to reach US$6.333 billion by 2023 from US$4.142 billion in 2017 growing at a CAGR of 7.33%. Breast cancer is defined as the malignant tumour formed in the tissues of the breast and has emerged as the leading cancer among women across the globe. Several tests are carried out by the doctors to diagnose the site of initiation as well as to know if the cancer has metastasised to the other body parts or not. The breast cancer market is expected to show a robust growth during the given forecast period. The growth in the market may be attributed to the rising prevalence of the breast cancer across the globe. As per Centers for Disease Control and Prevention 242,476 new cases of Female Breast Cancer were reported in 2015 with 41,523 deaths in US. Technological advancements such as introduction of hybrid imaging technique will also be augmenting the market growth during the given time. However, dearth of the skilled and trained professionals might hamper the growth of the breast cancer diagnosis market during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Breast Cancer Diagnosis market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Breast Cancer Diagnosis market.

Major industry players profiled as part of the report are among others.

Segmentation

By Diagnostic Techniques

Imaging
Surgical Biopsy
Lab Tests

By Cancer Type

BRCA Breast Cancer
ER & PR Breast Cancer
HER 2 Breast Cancer
EGFR Mutation Test Breast Cancer
Others

By End Users

Hospitals and Clinics
Cancer Research Centers
Diagnostic Laboratories
Ambulatory Surgical Centers

By Geography

North America
United States
Canada
Others

South America
Brazil
Argentina
Others

Europe
United Kingdom
Germany
France
Others

Middle East and Africa
Saudi Arabia
UAE
Israel
Others

Asia Pacific
China
India
Australia
South Korea
Others